BF Biosciences inks deal with Lucky Core

MG News | September 04, 2024 at 10:30 AM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

September 04, 2024 (MLN): BF Biosciences Limited (BFBL)has entered into a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI) for the products "Esopase IV 40 mg" & "Etipro IV 40 mg", the company's filing on PSX revealed.

BFBL is a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ).

In August, BF Biosciences successfully launched human insulin under the brand name "Ferulin".

BF Biosciences was established exclusively for the manufacture of biologicals and it is the first and only company in Pakistan currently to have a biotech manufacturing facility.

Copyright Mettis Link News

Related News

PSX Closing Bell: Bulls Close the Loop

Wahdat Poultry Farm secures Rs500m short-term financing facility from Saudi Pak

GAL FY26 profit surges 57%

Name	Price/Vol	%Chg/NChg
KSE100	169,043.20 125.46M	0.61% 1021.40
ALLSHR	102,244.62 384.35M	0.68% 687.69
KSE30	50,297.78 69.63M	0.61% 306.30
KMI30	240,616.56 58.52M	0.70% 1662.76
KMIALLSHR	66,324.04 212.30M	0.75% 491.93
BKTi	46,865.56 26.40M	0.56% 262.97
OGTi	34,899.40 10.33M	1.73% 593.21

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	76,435.00	76,520.00 76,250.00	-170.00 -0.22%
BRENT CRUDE	104.09	106.02 101.53	-1.74 -1.64%
RICHARDS BAY COAL MONTHLY	130.00	0.00 0.00	4.75 3.79%
ROTTERDAM COAL MONTHLY	138.50	0.00 0.00	-0.55 -0.40%
USD RBD PALM OLEIN	1,228.00	1,228.00 1,228.00	0.00 0.00%
CRUDE OIL - WTI	96.57	96.75 96.35	-5.34 -5.24%
SUGAR #11 WORLD	18.32	18.96 18.27	-0.57 -3.02%